Zhejiang Jingxin Pharmaceutical Hits Day High with Strong 6.61% Surge

Zhejiang Jingxin Pharmaceutical Co., Ltd. has experienced a significant uptick in its stock performance, gaining 6.61% on March 27, 2026. The stock reached an intraday high of CNY 15.58, reflecting a strong day of trading activity. This performance stands in contrast to the China Shanghai Composite, which saw a modest increase of 0.63% on the same day. Over the past week, Zhejiang Jingxin has shown a positive trend with a 2.38% increase, while the broader market has declined by 1.09%. However, the stock's performance over the past month indicates a decrease of 5.26%, slightly better than the Shanghai Composite's decline of 5.99%. In terms of annual performance, Zhejiang Jingxin has generated a return of 7.28%, although this is below the Shanghai Composite's 16.01% return. The company's market capitalization stands at CNY 12,025 million, categorizing it as a large-cap entity within the pharmaceuticals and biotechnology industry. With a price-to-earnings ratio of 23.00 and a dividend yield of 1.91%, the stock reflects a stable financial position amidst varying market conditions.